Qurient Co. Ltd (115180) - Cash Flow Conversion Efficiency

Latest as of September 2025: -0.062x

Based on the latest financial reports, Qurient Co. Ltd (115180) has a cash flow conversion efficiency ratio of -0.062x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (₩-3.15 Billion ≈ $-2.13 Million USD) by net assets (₩50.69 Billion ≈ $34.35 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See Qurient Co. Ltd defensive interval ratio to measure how many days the company can operate on defensive assets alone.

Qurient Co. Ltd - Cash Flow Conversion Efficiency Trend (2014–2024)

This chart illustrates how Qurient Co. Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data.

Qurient Co. Ltd Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Qurient Co. Ltd ranked by their cash flow conversion efficiency.

Company	Cash Flow Conversion Efficiency
Shenzhen King Brother Electronics Technology Co.Ltd. SHE:301041	N/A
Zhejiang Jihua Group Co Ltd SHG:603980	0.012x
Qingdao Copton Technology Co Ltd SHG:603798	0.016x
Pharmicell KO:005690	0.080x
Dexterra Group Inc TO:DXT	0.148x
Aprogen KIC Inc KO:007460	-0.041x
Brainsway Ltd NASDAQ:BWAY	0.015x
Beijing Beetech Inc SHE:300667	0.000x

Annual Cash Flow Conversion Efficiency for Qurient Co. Ltd (2014–2024)

The table below shows the annual cash flow conversion efficiency of Qurient Co. Ltd from 2014 to 2024. For the full company profile with market capitalisation and key ratios, see market cap of Qurient Co. Ltd.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2024-12-31	₩57.60 Billion ≈ $39.03 Million	₩-23.32 Billion ≈ $-15.80 Million	-0.405x	+14.10%
2023-12-31	₩46.62 Billion ≈ $31.59 Million	₩-21.97 Billion ≈ $-14.89 Million	-0.471x	+33.78%
2022-12-31	₩35.14 Billion ≈ $23.81 Million	₩-25.00 Billion ≈ $-16.94 Million	-0.712x	-57.89%
2021-12-31	₩54.08 Billion ≈ $36.65 Million	₩-24.37 Billion ≈ $-16.52 Million	-0.451x	-28.45%
2020-12-31	₩56.57 Billion ≈ $38.33 Million	₩-19.85 Billion ≈ $-13.45 Million	-0.351x	+74.59%
2019-12-31	₩17.38 Billion ≈ $11.78 Million	₩-24.00 Billion ≈ $-16.26 Million	-1.381x	-294.23%
2018-12-31	₩39.41 Billion ≈ $26.70 Million	₩-13.80 Billion ≈ $-9.36 Million	-0.350x	+59.55%
2017-12-31	₩14.53 Billion ≈ $9.85 Million	₩-12.59 Billion ≈ $-8.53 Million	-0.866x	-113.10%
2016-12-31	₩24.35 Billion ≈ $16.50 Million	₩-9.90 Billion ≈ $-6.71 Million	-0.406x	+84.40%
2015-12-31	₩2.89 Billion ≈ $1.96 Million	₩-7.54 Billion ≈ $-5.11 Million	-2.605x	-950.52%
2014-12-31	₩-21.68 Billion ≈ $-14.69 Million	₩-6.64 Billion ≈ $-4.50 Million	0.306x	--

About Qurient Co. Ltd

KQ:115180 Korea Biotechnology

Market Cap

$579.17 Million

₩854.63 Billion KRW

Market Cap Rank

#11641 Global

#325 in Korea

Share Price

₩24500.00

Change (1 day)

-8.58%

52-Week Range

₩9950.00 - ₩50900.00

All Time High

₩50900.00